默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRK 默沙东

交易中 05-08 15:48:55 EDT

77.76

-1.36

-1.73%

最高78.80	最低76.93	成交量1,072万
今开78.65	昨收79.12	日振幅2.36%
总市值1,952亿	流通市值1,949亿	总股本25.11亿
成交额8.35亿	换手率0.43%	流通股本25.07亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRK","market":"US","secType":"STK","nameCN":"默沙东","latestPrice":77.755,"timestamp":1746733735119,"preClose":79.12,"halted":0,"volume":10722544,"delay":0,"floatShares":2507013854,"shares":2511031253,"eps":6.878679,"marketStatus":"交易中","change":-1.365,"latestTime":"05-08 15:48:55 EDT","open":78.645,"high":78.8,"low":76.93,"amount":834961338.1295199,"amplitude":0.023635,"askPrice":77.76,"askSize":144,"bidPrice":77.75,"bidSize":199,"shortable":3,"etf":0,"ttmEps":6.878679,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746734400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":-745790400000,"exchange":"NYSE","adjPreClose":79.12,"dividendRate":0.04064,"preHourTrading":{"tag":"盘前","latestPrice":78.5,"preClose":79.12,"latestTime":"09:29 EDT","volume":17276,"amount":1353723.8646399998,"timestamp":1746710998065},"postHourTrading":{"tag":"盘后","latestPrice":78.2,"preClose":79.12,"latestTime":"19:58 EDT","volume":544458,"amount":42964908.3591,"timestamp":1746662337658},"volumeRatio":0.924127,"optionData":{"bulkOrders":[{"symbol":"MRK","call":false,"expireDate":1747368000000,"strike":"90.0","timestamp":1746733392517,"price":12.28,"volume":2600,"amount":3192800,"type":"+"},{"symbol":"MRK","call":false,"expireDate":1747368000000,"strike":"95.0","timestamp":1746733392446,"price":17.28,"volume":2600,"amount":4492800,"type":"-"}]},"impliedVol":0.3884,"impliedVolPercentile":0.912},"requestUrl":"/m/hq/s/MRK","defaultTab":"news","newsList":[{"id":"2533294323","title":"默沙东，中国区大幅下跌62%的背后是什么？","url":"https://stock-news.laohu8.com/highlight/detail?id=2533294323","media":"药闻康策","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533294323?lang=zh_cn&edition=full","pubTime":"2025-05-08 00:01","pubTimestamp":1746633715,"startTime":"0","endTime":"0","summary":"2025年，默沙东发布的财报显示，其中国区销售额同比骤降62%，创下近十年最大跌幅。此外，信达生物的PD-1/VEGF双抗药物凭借适应症拓展，直接冲击默沙东的联合用药市场。产品管线依赖与创新断层默沙东中国区收入仍依赖Keytruda等成熟产品，占其总营收的60%，而2025年其管线中仅有一款针对肝癌的TIGIT抑制剂获批，远落后于国内药企在ADC、双抗等领域的密集突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508043244a6d6bf7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508043244a6d6bf7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1934455194.USD","SG9999014559.SGD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU0265550359.USD","LU1699723380.USD","LU1934455863.HKD","LU1069347547.HKD","LU0266013472.USD","IE00BFTCPJ56.SGD","LU1291159041.SGD","LU1989772840.SGD","LU0122379950.USD","LU2324357040.USD","LU0006306889.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","BK4550","IE00B1BXHZ80.USD","LU0861579265.USD","LU1023059063.AUD","BK4007","LU2361045086.USD","LU0211331839.USD","LU1430594728.SGD","SGXZ57979304.SGD","LU0265550946.USD","LU1934455277.USD","LU1037948897.HKD","SG9999001176.SGD","LU1037948541.HKD","LU0320765646.SGD","LU0203347892.USD","LU1974910355.USD","LU2089984988.USD","IE00BLSP4452.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","LU1929549753.HKD","IE00BBT3K403.USD","SG9999002232.USD","LU0985320562.USD","MRK","LU0965508806.USD","LU0965509283.SGD","LU0965509010.AUD","LU0203345920.USD","SG9999002224.SGD","LU1571399168.USD","LU0289739699.SGD"],"gpt_icon":1},{"id":"2533398464","title":"司美格鲁肽登顶药王！诺和诺德、默沙东一季报揭晓战略分野","url":"https://stock-news.laohu8.com/highlight/detail?id=2533398464","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533398464?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:33","pubTimestamp":1746617619,"startTime":"0","endTime":"0","summary":"当前，诺和诺德糖尿病业务的支柱产品已经由胰岛素变更为现象级产品GLP-1。HPV疫苗下降四成对于去年险胜司美格鲁肽，而在今年一季度便丢掉“药王”宝座的K药，业界原本便抱有一定预期。其中，默沙东的制药业务收入为136.38亿美元，同比下降1%，原因是受疫苗、抗病毒、免疫等板块拖累。默沙东业绩下滑的主要原因仍要归咎于HPV疫苗Gardasil/Gardasil 9。默沙东表示，Gardasil/Gardasil 9的销售额下滑主要是由于中国地区需求下降，库存仍居高不下。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507194813a6d651a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507194813a6d651a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1037948541.HKD","IE00BBT3K403.USD","NVO","LU1929549753.HKD","MRK","LU0861579265.USD","LU1291159041.SGD","BK4550","LU0965509101.SGD","SG9999001176.USD","SG9999014559.SGD","BK4559","BK4599","LU1934455194.USD","LU2361044865.SGD","SG9999013999.USD","LU2023250843.SGD","LU2361045086.USD","BK4534","LU2112291526.USD","BK4532","LU2089984988.USD","BK4585","LU1699723380.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","IE00B1BXHZ80.USD","LU2324357040.USD","LU0070302665.USD","LU1974910355.USD","LU0289739699.SGD","LU0266013472.USD","SG9999014542.SGD","LU0203347892.USD","LU1035773651.USD","BK4588","LU1023059063.AUD","LU1983299246.USD","IE00BSNM7G36.USD","SG9999001440.SGD","LU0965509283.SGD","SG9999001176.SGD","LU1585245621.USD","LU0208291251.USD","IE00BN8TJ469.HKD","SG9999002232.USD","SG9999014567.USD","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","LU1571399168.USD"],"gpt_icon":1},{"id":"2533967262","title":"司美格鲁肽全球销售额超过抗癌药物K药 暂时坐上了全球“药王”宝座","url":"https://stock-news.laohu8.com/highlight/detail?id=2533967262","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533967262?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:10","pubTimestamp":1746609016,"startTime":"0","endTime":"0","summary":"2025年第一季度，司美格鲁肽全球销售额终于超过K药，暂时坐上了全球“药王”宝座。诺和诺德在一季报中表示，全球约有10亿人患有肥胖症，但只有数百万人接受治疗，公司继续在全球推广Wegovy。不过，司美格鲁肽仍要直面与礼来的GLP-1/GIP双重激动剂替尔泊肽的竞争，且两者的竞争日趋白热化。\n\n\r\n            责任编辑：山上","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/05/07171050194878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU1037948541.HKD","IE00BBT3K403.USD","LU0238689110.USD","LU1430594728.SGD","LU1929549753.HKD","MRK","LU1037948897.HKD","LU1989772840.SGD","LU0965509101.SGD","SG9999001176.USD","BK4559","LU1934455194.USD","LU1116320901.HKD","SG9999013999.USD","LU2023250843.SGD","LU2361045086.USD","LU0122379950.USD","LU1162221912.USD","LU2112291526.USD","LU1934455277.USD","LU1699723380.USD","LU0058720904.USD","LU2361044949.HKD","LU0006306889.USD","LU2324357040.USD","LU1974910355.USD","LU0965509010.AUD","SG9999002224.SGD","SG9999015341.SGD","LU2468319806.SGD","LU0266013472.USD","SG9999014542.SGD","LU0320765646.SGD","LU1035773651.USD","LU1983299246.USD","LU2106854487.HKD","LU0265550946.USD","SG9999015358.SGD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","SG9999001176.SGD","SG9999014575.USD","LU0208291251.USD","LU0203345920.USD","LU1941712348.USD","LU1066051498.USD","LU1989772923.USD","LU1066051811.HKD","LU1571399168.USD"],"gpt_icon":0},{"id":"2533665674","title":"司美格鲁肽全球销售额超过抗癌药物K药 暂时坐上了全球“药王”宝座","url":"https://stock-news.laohu8.com/highlight/detail?id=2533665674","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533665674?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:02","pubTimestamp":1746608529,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1551013342.USD","LU1929549753.HKD","LLY","GLP","LU1623119135.USD","LU0471298694.HKD","LU1868836591.USD","IE00BLSP4452.SGD","LU0096364046.USD","LU1989771016.USD","LU2211815571.USD","LU2361044865.SGD","LU1548497426.USD","BK4550","IE000M9KFDE8.USD","LU1974910355.USD","LU0211331839.USD","LU0320765059.SGD","SG9999014906.USD","LU0965508806.USD","LU1035775433.USD","LU1934455277.USD","LU2471134523.USD","LU0417517546.SGD","LU1291159041.SGD","LU2237438978.USD","LU1069344957.HKD","LU2471134796.USD","BK4534","LU2237443382.USD","SGXZ57979304.SGD","LU1720051017.SGD","BK4516","NVO","BK4581","SGXZ51526630.SGD","SGXZ99366536.SGD","BK4590","LU0640476718.USD","MRK","LU1064131342.USD","LU2552382132.HKD","SG9999014542.SGD","LU0094547139.USD","LU2023250843.SGD","LU0203202063.USD","LU0289739699.SGD","LU2750360641.GBP","LU0256863902.USD","LU0061475181.USD"],"gpt_icon":0},{"id":"2533674179","title":"一季度药物市场激战：司美格鲁肽收入超80亿美元力压K药，预定“药王”桂冠","url":"https://stock-news.laohu8.com/highlight/detail?id=2533674179","media":"21财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533674179?lang=zh_cn&edition=full","pubTime":"2025-05-07 17:01","pubTimestamp":1746608498,"startTime":"0","endTime":"0","summary":"一季度，诺和诺德司美格鲁肽合计收入569.34亿丹麦克朗，同比增长31%，这一业绩高于礼来的替尔泊肽。根据5月1日礼来公司发布的第一季度业绩报告，礼来公司第一季度营收127.29亿美元，同比增长45%；净利润27.59亿美元，同比增长23%。礼来替尔泊肽双靶点药物、诺和诺德口服司美格鲁肽剂型有望成为两家跨国巨头的新增长极。第一季度，司美格鲁肽的合计收入已超越默沙东的帕博利珠单抗（K药），有望夺得2025年度“药王”宝座。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050717015394ef0dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050717015394ef0dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0070302665.USD","NVO","BK4559","BK4599","LU0122379950.USD","LU1989771016.USD","LU1037948897.HKD","LU0006306889.USD","LU0154236417.USD","LU0234572021.USD","LU0965509101.SGD","LU0265550359.USD","LU1061106388.HKD","LU1116320901.HKD","SG9999015341.SGD","LU1116320737.USD","LU1069347547.HKD","IE00B2B36J28.USD","LU1066051225.USD","IE00BN8TJ469.HKD","LU2461242641.AUD","LU1934455194.USD","LU1093756168.USD","LU2468319806.SGD","SG9999014559.SGD","LU1430594728.SGD","LU0203347892.USD","IE000M9KFDE8.USD","LU0965509010.AUD","LU1989772923.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU1929549753.HKD","LU2361045086.USD","MRK","LU2106854487.HKD","LU2324357040.USD","LU1057294990.SGD","IE00BJJMRZ35.SGD","LU1974910355.USD","LU1983299246.USD","IE0009355771.USD","LU1066053197.SGD","LU1093756325.SGD","SG9999001176.USD","LU0289739699.SGD","LU2361044865.SGD","LU0861579265.USD","LU1941712348.USD","LU1934455863.HKD"],"gpt_icon":1},{"id":"2531703906","title":"默沙东研发（中国）有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2531703906","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531703906?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:27","pubTimestamp":1745998045,"startTime":"0","endTime":"0","summary":"4月30日，据CDE官网消息，默沙东研发（中国）有限公司联合申请药品“注射用MK-2870”，获得临床试验默示许可，受理号CXSB2500040。公示信息显示，药品“注射用MK-2870”适应症：非小细胞肺癌。默沙东研发（中国）有限公司，成立于2012年，位于北京市，是一家以从事研究和试验发展为主的企业。企业注册资本2000万美元，实缴资本2000万美元。通过天眼查大数据分析，默沙东研发（中国）有限公司参与招投标项目9次，专利信息3条，此外企业还拥有行政许可7个。主要股东信息显示，默沙东研发（中国）有限公司由默沙东研发有限公司持股100%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30152750039951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0965508806.USD","LU0289739699.SGD","LU1093756325.SGD","LU2089984988.USD","LU1116320737.USD","LU0122379950.USD","LU1066053197.SGD","LU1035773651.USD","LU1941712264.USD","LU1430594728.SGD","LU1941712348.USD","LU1023059063.AUD","LU0265550359.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU1291159041.SGD","LU1974910355.USD","BK4533","SG9999014575.USD","IE00BN8TJ469.HKD","MRK","BK4516","LU1571399168.USD","BK4585","LU0211331839.USD","LU0203347892.USD","SG9999014542.SGD","LU2023250843.SGD","BK4007","LU1917777945.USD","LU0965509283.SGD","LU0106261372.USD","SG9999014567.USD","BK4534","BK4588","IE00BLSP4452.SGD","LU1037948897.HKD","LU0861579265.USD","BK1576","LU2023250504.SGD","LU1989772840.SGD","LU0320765646.SGD","SG9999001176.USD","IE00B1BXHZ80.USD","LU0058720904.USD","03347","SG9999002224.SGD","LU0070302665.USD","LU2461242641.AUD"],"gpt_icon":0},{"id":"2531788875","title":"默沙东(MRK.US)拟斥资10亿美元在美国建厂 以确保Keytruda供应免受关税冲击","url":"https://stock-news.laohu8.com/highlight/detail?id=2531788875","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531788875?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:28","pubTimestamp":1745922508,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据报道，默沙东 正寻求在特拉华州投资10亿美元建立工厂，扩大其在美国的制造业务。随着针对行业的关税迫在眉睫，默沙东成为最新一家增加美国国内投资的制药公司。但这款占默沙东近半数营收的药物，预计将在2028年面临低价竞争和政府定价谈判。默沙东预计将于今年晚些时候推出一款更易于使用的Keytruda版本，以期保住原研药30%至40%的市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"默沙东(MRK.US)拟斥资10亿美元在美国建厂 以确保Keytruda供应免受关税冲击","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU1162221912.USD","LU2461242641.AUD","SG9999015341.SGD","SG9999002232.USD","LU0265550946.USD","SG9999014542.SGD","SG9999014575.USD","IE00B4R5TH58.HKD","LU0234572021.USD","LU1989772840.SGD","BK4585","SG9999001440.SGD","LU0208291251.USD","BK4588","LU0203347892.USD","IE00BLSP4452.SGD","LU1093756325.SGD","LU1035773651.USD","MRK","SG9999014567.USD","IE00BJJMRZ35.SGD","LU1941712348.USD","LU1929549753.HKD","LU1037948897.HKD","LU0006306889.USD","SGXZ57979304.SGD","SG9999002224.SGD","IE0002141913.USD","BK4533","LU0289739699.SGD","IE000M9KFDE8.USD","LU0320765489.SGD","LU1934455277.USD","LU0266013472.USD","BK4516","BK4007","LU1037948541.HKD","LU1941712264.USD","LU1974910355.USD","LU2089984988.USD","BK4550","SG9999014559.SGD","LU1934455194.USD","LU1066051811.HKD","LU1917777945.USD","SG9999001176.SGD","LU0965509010.AUD"],"gpt_icon":0},{"id":"2530288734","title":"每日全球并购：默克收购SpringWorks进入后期谈判 | 中润光学收购戴斯光电控股权（4/28）","url":"https://stock-news.laohu8.com/highlight/detail?id=2530288734","media":"晨哨并购","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530288734?lang=zh_cn&edition=full","pubTime":"2025-04-28 20:36","pubTimestamp":1745843760,"startTime":"0","endTime":"0","summary":"-每日资讯-1、默克收购SpringWorks进入后期谈判德国默克公司正在与美国SpringWorks Therapeutics就收购事宜进行后期谈判，交易金额约35亿美元。默克有望通过此次收购获得一种新批准的罕见疾病药物，并扩大其癌症治疗产品组合。此次收购将是默克近年来最大的制药交易之一，旨在推动其癌症治疗业务的发展。SpringWorks于2019年上市，专注于罕见癌症和遗传疾病的药物开发，其疗法Ogsiveo已获美国批准用于治疗硬纤维瘤，基因疾病药物gomez kli也于今年2月获批。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-04-28/doc-ineutqhq5074247.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1571399168.USD","LU1116320901.HKD","LU1061106388.HKD","LU0234572021.USD","IE00BBT3K403.USD","LU0965509101.SGD","LU2089984988.USD","LU2468319806.SGD","LU0058720904.USD","LU0238689110.USD","LU1989772923.USD","SG9999002232.USD","SG9999014542.SGD","SG9999001440.SGD","LU0289739699.SGD","BK4534","IE00BFTCPJ56.SGD","SG9999014559.SGD","LU1291159041.SGD","SG9999013999.USD","688307","LU1929549753.HKD","LU1066051498.USD","MRK","LU2361044865.SGD","LU0208291251.USD","LU1983299246.USD","LU1069347547.HKD","BK4559","IE000M9KFDE8.USD","IE00B2B36J28.USD","LU0965508806.USD","SG9999001176.USD","LU1941712348.USD","SGXZ57979304.SGD","LU1037948897.HKD","LU1066053197.SGD","LU1585245621.USD","LU1699723380.USD","LU1934455194.USD","LU0965509010.AUD","IE00BN8TJ469.HKD","LU1934455277.USD","LU2361045086.USD","IE00B4R5TH58.HKD","BK4007","IE0009355771.USD","LU0265550946.USD","LU0203347892.USD","LU0266013472.USD"],"gpt_icon":0},{"id":"1133351274","title":"高盛：美股医药股Q1业绩令人欣慰，行业情绪略微趋于积极","url":"https://stock-news.laohu8.com/highlight/detail?id=1133351274","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133351274?lang=zh_cn&edition=full","pubTime":"2025-04-28 17:44","pubTimestamp":1745833489,"startTime":"0","endTime":"0","summary":"在某些情况下甚至优于预期。","market":"us","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/content/detail/1286394.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["JNJ","BMY","MRK"],"gpt_icon":1},{"id":"2530440593","title":"德国默克以39亿美元收购美国生物科技公司SpringWorks","url":"https://stock-news.laohu8.com/highlight/detail?id=2530440593","media":"金吾财讯","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530440593?lang=zh_cn&edition=full","pubTime":"2025-04-28 16:14","pubTimestamp":1745828059,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德国医疗保健和材料集团默克集团周一表示，将以 39 亿美元的股权价值收购美国生物科技公司 SpringWorks Therapeutics，以增强其抗癌药物业务。扣除 SpringWorks 的现金持有量后，企业价值相当于 34 亿美元。默克集团在一份声明中表示，此次交易将以现有现金和新债务为资金来源，预计将在2027年增加默克经特殊项目调整后的每股收益。总部位于康涅狄格州斯坦福的 SpringWorks 公司于 2019 年在纽约上市，致力于开发治疗癌症和罕见肿瘤的药物。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ODI2NGE1NjlmODgxZDI1NzFmMmQ4ODQzNDA1OTI5NjU2Mg==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287913","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","LU1037948897.HKD","IE00BLSP4239.USD","LU1061106388.HKD","LU1941712264.USD","MRK","LU0211331839.USD","BK4559","LU1929549753.HKD","LU1934455277.USD","BK4588","BK4534","LU2023250843.SGD","SGXZ57979304.SGD","LU1989772923.USD","LU1066051811.HKD","LU0208291251.USD","LU0238689110.USD","LU0266013472.USD","SG9999014567.USD","IE00BBT3K403.USD","LU1974910355.USD","LU0265550359.USD","LU1066051498.USD","IE0002141913.USD","LU1291159041.SGD","IE00BSNM7G36.USD","LU1983299246.USD","SG9999014559.SGD","IE00B4R5TH58.HKD","BK4516","LU0289739699.SGD","IE00BN8TJ469.HKD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2324357040.USD","SG9999001440.SGD","LU2023250504.SGD","LU2089984988.USD","SG9999002232.USD","LU2468319806.SGD","LU2112291526.USD","LU1066051225.USD","159837","IE00B1BXHZ80.USD","LU0965508806.USD","BK4007","SG9999015341.SGD","LU0106261372.USD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2530441925","title":"德国默克宣布39亿美元收购美国生物技术公司SpringWorks","url":"https://stock-news.laohu8.com/highlight/detail?id=2530441925","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530441925?lang=zh_cn&edition=full","pubTime":"2025-04-28 15:20","pubTimestamp":1745824834,"startTime":"0","endTime":"0","summary":"德国医疗保健和材料集团默克周一表示，已达成协议，将以39亿美元的股权价值收购美国生物技术公司SpringWorks Therapeutics，以加强其抗癌药物业务。默克表示，扣除SpringWorks持有的现金，每股47美元的现金收购价格代表约39亿美元的股权价值，相当于34亿美元的企业价值。默克上周表示，两家公司就每股约47美元的报价进行了后期谈判。默克在一份声明中表示，这笔交易将由可用现金和新债务提供资金，预计将增加默克2027年经特殊项目调整后的每股盈利。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2025/04/28152049946884.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1430594728.SGD","LU0320765489.SGD","LU0006306889.USD","LU2112291526.USD","IE00B4R5TH58.HKD","LU1989771016.USD","LU0965509010.AUD","LU0861579265.USD","LU2023250843.SGD","LU2089984988.USD","SG9999015341.SGD","LU1057294990.SGD","SG9999015358.SGD","SG9999014542.SGD","LU0234572021.USD","LU0070302665.USD","LU2468319806.SGD","LU0208291251.USD","IE00BLSP4239.USD","LU0265550359.USD","IE00BJT1NW94.SGD","BK4588","LU0058720904.USD","LU0106261372.USD","LU1162221912.USD","LU0265550946.USD","LU0266013472.USD","BK4007","LU1934455277.USD","LU1934455863.HKD","LU1989772840.SGD","SG9999014575.USD","LU1917777945.USD","LU0122379950.USD","LU1571399168.USD","LU1974910355.USD","LU1983299246.USD","LU1989772923.USD","IE00BJJMRZ35.SGD","MRK","IE0002141913.USD","LU1585245621.USD","BK4534","LU1066051811.HKD","LU2023250504.SGD","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU1116320901.HKD","LU2361045086.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2530448653","title":"市场消息：默克将以每股47美元现金收购SPRING WORKS。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530448653","media":"金融界","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530448653?lang=zh_cn&edition=full","pubTime":"2025-04-28 14:06","pubTimestamp":1745820366,"startTime":"0","endTime":"0","summary":"市场消息：默克将以每股47美元现金收购SPRING WORKS。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/28140649944706.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1093756168.USD","LU0965509101.SGD","LU2023250504.SGD","LU2361045086.USD","LU0320765489.SGD","LU2106854487.HKD","BK4559","SG9999014559.SGD","LU0006306889.USD","LU2461242641.AUD","LU1941712264.USD","SG9999015358.SGD","LU1430594728.SGD","LU1571399168.USD","LU1934455863.HKD","LU0211331839.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","SG9999014542.SGD","BK4007","LU1023059063.AUD","LU0266013472.USD","LU2023250843.SGD","MRK","LU1989771016.USD","IE000M9KFDE8.USD","LU1162221912.USD","LU0203347892.USD","SGXZ57979304.SGD","IE0002141913.USD","LU2468319806.SGD","SG9999002224.SGD","SG9999001176.USD","LU1929549753.HKD","LU0289739699.SGD","SG9999001440.SGD","LU1917777945.USD","SG9999014567.USD","LU2089984988.USD","LU1069347547.HKD","LU1066051498.USD","IE0009355771.USD","LU1934455277.USD","LU2361044865.SGD","LU1934455194.USD","SG9999015341.SGD","LU0861579265.USD","LU0965508806.USD","SG9999002232.USD","LU1974910355.USD"],"gpt_icon":0},{"id":"2531294179","title":"由辉瑞一手孵化，现在拟被默克收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2531294179","media":"生物制药小编","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531294179?lang=zh_cn&edition=full","pubTime":"2025-04-28 09:20","pubTimestamp":1745803200,"startTime":"0","endTime":"0","summary":"不出意外，SpringWorks Therapeutics要被德国默克收购了。近日，两家公司已就收购价上达成一致，德国默克将以每股47美元收购SpringWorks，收购总价约为35亿美元，如果后续收购工作顺利，该交易将在下周内完成。由辉瑞一手孵化SpringWorks成立于2017年，是一家专注于癌症和罕见病药物开发的Biotech公司，2019年在纳斯达克证券交易所上市。SpringWorks可以算是由辉瑞一手孵化，SpringWorks的创始人是辉瑞的前研发主管Lara S. Sullivan。这两款药物现在都成功批准上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429073247a46b2267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429073247a46b2267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0965509101.SGD","LU2106854487.HKD","LU1989772840.SGD","MRK","BK4581","BK4550","LU1066051225.USD","IE00B1BXHZ80.USD","LU1934455277.USD","LU0170899867.USD","LU0058720904.USD","LU1699723380.USD","SG9999015341.SGD","LU2023250504.SGD","LU1057294990.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU1974910355.USD","SG9999015358.SGD","LU1894683264.USD","LU0456855351.SGD","LU1093756325.SGD","LU1066051811.HKD","LU0265550946.USD","LU1894683348.USD","LU1929549753.HKD","LU0985481810.HKD","LU2112291526.USD","LU0965508806.USD","SG9999001176.SGD","LU0289739699.SGD","BK4592","LU0006306889.USD","LU1061106388.HKD","PFE","LU0868494617.USD","BK4533","LU2324357040.USD","LU2361045086.USD","IE0002270589.USD","BK4007","IE00B4R5TH58.HKD","BK4516","LU1585245621.USD","LU0234572021.USD","LU1941712348.USD","LU1066051498.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","SG9999013999.USD"],"gpt_icon":1},{"id":"2530456611","title":"ADC冰火交融：映恩、乐普、恒瑞等再获进展，默沙东、BMS选择性撤退撤退","url":"https://stock-news.laohu8.com/highlight/detail?id=2530456611","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530456611?lang=zh_cn&edition=full","pubTime":"2025-04-27 20:08","pubTimestamp":1745755715,"startTime":"0","endTime":"0","summary":"目前MRG003已经在国内上市审核阶段，并被纳入优先审评，有望成为全球首款获批上市的EGFR ADC。值得一提的是，此前ADC明星企业映恩生物港交所上市首日大涨116%。一方面，部分企业如乐普生物、映恩生物在合作与创新中不断前进；另一方面，默沙东、BMS、Elevation、东耀药业等企业却因各种原因终止了相关临床进程，这种“冰火两重天”的局面值得行业深思。2024年8月，MRG003治疗复发或转移性鼻咽癌获得了FDA的突破性疗法认证，预计将于2026年初获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427223203a6ca7f62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427223203a6ca7f62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","LU1064130708.USD","BK0188","LU2148510915.USD","BK0239","BK0060","LU2488822045.USD","BK0012","LU1969619763.USD","LU2328871848.SGD","BK0028","600276","LU0405327494.USD","BK0183","BK0196","LU0405327148.USD","LU1328615791.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2530948353","title":"高盛下调默沙东目标价至99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530948353","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530948353?lang=zh_cn&edition=full","pubTime":"2025-04-27 12:56","pubTimestamp":1745729807,"startTime":"0","endTime":"0","summary":"高盛将默沙东的目标价从103美元下调至99美元，维持“买入”评级。(格隆汇)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/27125649925367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MRK"],"gpt_icon":0},{"id":"2530880874","title":"每日医刻｜礼来起诉四家药企；默克洽谈收购生物制药公司SpringWorks","url":"https://stock-news.laohu8.com/highlight/detail?id=2530880874","media":"财健道","labels":["corporation","policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530880874?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:51","pubTimestamp":1745725880,"startTime":"0","endTime":"0","summary":"将“财健道”设为星标持续关注，不错过好看每日医刻1映恩生物与阿斯利康达成合作4月25日。4德国默克洽谈收购生物制药公司SpringWorks4月25日，德国默克集团证实，与生物制药公司SpringWorksTherapeutics就潜在收购事宜开展后期洽谈，讨论的收购价为每股约47美元。默克集团表示，双方尚未做出最终决定，也未签订有约束力协议。5礼来起诉四家药企日前，据媒体报道，礼来正在起诉四家远程医疗公司，因为他们销售了礼来减重药物Zepbound和糖尿病治疗药物Mounjaro的仿制版本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427124546a6c9fc4d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427124546a6c9fc4d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","LU1069344957.HKD","LU2211815571.USD","SG9999015978.USD","SGXZ31699556.SGD","LU0203347892.USD","LU0672654240.SGD","LU1116320901.HKD","LU0238689110.USD","LU1623119135.USD","SGXZ51526630.SGD","IE00B1BXHZ80.USD","SG9999014914.USD","LU0122379950.USD","BK4581","LU2471134796.USD","LU0058720904.USD","LU2063271972.USD","LU2471134523.USD","LU1868836914.USD","MRK","LU1057294990.SGD","LU0640476718.USD","LLY","LU0320765059.SGD","LU2237443549.SGD","LU0211331839.USD","LU1934455277.USD","IE00BJLML261.HKD","LU0471298777.SGD","LU1066051225.USD","LU1814569148.SGD","LU2265009873.SGD","LU2361045086.USD","LU1035775433.USD","LU0943347566.SGD","LU1983299246.USD","LU1127390331.HKD","LU2237443622.USD","LU1974910355.USD","BK4559","LU0070302665.USD","IE00B4R5TH58.HKD","LU1941712264.USD","SG9999002232.USD","SG9999002224.SGD","LU2237443895.HKD","LU2357305700.SGD","BK4534","LU1066053197.SGD"],"gpt_icon":1},{"id":"2530812104","title":"新华健康｜依沃西单抗NSCLC适应症获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2530812104","media":"经济参考网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530812104?lang=zh_cn&edition=full","pubTime":"2025-04-26 22:08","pubTimestamp":1745676511,"startTime":"0","endTime":"0","summary":"4月25日，康方生物宣布，公司独立自主研发的全球首创PD-1/VEGF双特异性抗体新药依达方（通用名：依沃西单抗注射液）单药，用于PD-L1阳性（TPS≥1%）的表皮生长因子受体（EGFR）基因突变阴性和间变性淋巴瘤激酶（ALK）阴性的局部晚期或转移性非小细胞肺癌（NSCLC）的一线治疗的新药上市申请（sNDA），已获得中国国家药品监督管理局（NMPA）批准上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504263389731988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999014559.SGD","LU2112291526.USD","SG9999014567.USD","LU0265550946.USD","LU2468319806.SGD","LU0320765489.SGD","LU1023059063.AUD","LU2023250504.SGD","SG9999015341.SGD","SG9999001440.SGD","SGXZ57979304.SGD","ALK","LU2023250843.SGD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","BK4500","BK4559","SG9999013999.USD","LU0417516571.SGD","LU0203345920.USD","BK1574","LU0965509010.AUD","LU1057294990.SGD","MRK","IE0002141913.USD","09926","LU2461242641.AUD","LU1116320737.USD","BK4585","SG9999001176.USD","LU0238689110.USD","BK4007","LU1585245621.USD","BK4588","IE00BJT1NW94.SGD","LU1941712264.USD","LU2488822045.USD","IE00BJJMRZ35.SGD","LU1989772840.SGD","SG9999015358.SGD","LU2361045086.USD","LU1066051811.HKD","LU1699723380.USD","LU2361044865.SGD","LU0070302665.USD","LU1941712348.USD","BK4550","LU0965509283.SGD","LU1069347547.HKD","SG9999014542.SGD"],"gpt_icon":0},{"id":"2530941817","title":"港股异动 | 环球新材国际(06616)盘中急升逾20% 公司此前收购默克旗下的全球表现解决方案业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2530941817","media":"智通财经","labels":["corporation","merge","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530941817?lang=zh_cn&edition=full","pubTime":"2025-04-25 11:11","pubTimestamp":1745550674,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，环球新材国际盘中急升逾20%，截至发稿，涨5.23%，报3.82港元，成交额4667.73万港元。2023年以来，公司相继完成对韩国CQV的并购整合、并且与德国默克达成对其表面解决方案业务的收购，通过跨国并购，环球新材国际正加速打开国际市场，成为一家新材料跨国企业。国证国际此前指出，环球新材国际于24年7月与默克集团签订收购协议，以6.65亿欧元的代价收购默克旗下的全球表现解决方案业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1284686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999002224.SGD","LU0289739699.SGD","LU0965509101.SGD","LU1035773651.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU0985320562.USD","IE00BN8TJ469.HKD","LU0070302665.USD","LU1023059063.AUD","LU1037948541.HKD","LU1585245621.USD","LU0965509283.SGD","SG9999015341.SGD","SG9999014559.SGD","BK4533","SG9999001176.SGD","LU0965508806.USD","IE00B2B36J28.USD","LU2468319806.SGD","LU1699723380.USD","LU2023250843.SGD","LU0965509010.AUD","SG9999001440.SGD","LU1974910355.USD","LU0006306889.USD","MRK","LU1116320737.USD","LU0265550359.USD","BK4007","LU1934455194.USD","LU2089984988.USD","LU0203345920.USD","LU2106854487.HKD","LU0211331839.USD","LU1093756168.USD","IE00BJT1NW94.SGD","LU2023250504.SGD","BK4585","LU2112291526.USD","06616","LU0320765489.SGD","LU1934455277.USD","LU2461242641.AUD","SG9999001176.USD","SG9999014542.SGD","IE00BLSP4239.USD","BK4550","BK1129","BK4516"],"gpt_icon":0},{"id":"2530396996","title":"默克证实与springworks的谈判已进入后期阶段。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530396996","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530396996?lang=zh_cn&edition=full","pubTime":"2025-04-25 04:53","pubTimestamp":1745528014,"startTime":"0","endTime":"0","summary":"默克证实与springworks的谈判已进入后期阶段。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/25045349859508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BBT3K403.USD","LU0265550946.USD","LU2023250504.SGD","SG9999002232.USD","LU0861579265.USD","LU2461242641.AUD","SG9999014567.USD","BK4007","BK4559","LU1699723380.USD","SG9999014542.SGD","LU1066051811.HKD","LU2023250843.SGD","LU1974910355.USD","SG9999001176.USD","LU2468319806.SGD","LU1934455863.HKD","SG9999001176.SGD","LU0203347892.USD","LU1989772923.USD","BK4550","LU2361044949.HKD","LU0965509010.AUD","LU0289739699.SGD","LU1917777945.USD","LU1934455194.USD","LU0965508806.USD","IE000M9KFDE8.USD","SG9999013999.USD","SG9999014575.USD","LU1066051498.USD","LU0070302665.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","LU1066053197.SGD","LU1116320737.USD","IE00BLSP4239.USD","IE00BN8TJ469.HKD","MRK","LU0265550359.USD","LU1291159041.SGD","IE00B1BXHZ80.USD","LU0320765646.SGD","BK4533","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1116320901.HKD","LU1989771016.USD","LU1069347547.HKD","LU2361045086.USD"],"gpt_icon":0},{"id":"2530596450","title":"市场消息：默克接近以约35亿美元收购springworks。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530596450","media":"金融界","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530596450?lang=zh_cn&edition=full","pubTime":"2025-04-25 03:07","pubTimestamp":1745521641,"startTime":"0","endTime":"0","summary":"市场消息：默克接近以约35亿美元收购springworks。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/25030749858918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BLSP4452.SGD","SG9999015358.SGD","IE000M9KFDE8.USD","LU0965509010.AUD","IE00BJJMRZ35.SGD","LU0965508806.USD","LU1023059063.AUD","LU0965509101.SGD","LU1934455194.USD","SG9999015341.SGD","LU0058720904.USD","LU1291159041.SGD","LU1093756325.SGD","IE00B2B36J28.USD","LU0106261372.USD","BK4007","LU2023250843.SGD","LU0266013472.USD","BK4585","LU0985320562.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU0861579265.USD","IE00BLSP4239.USD","IE0009355771.USD","LU1571399168.USD","IE00B1BXHZ80.USD","BK4534","LU1989772923.USD","LU2361044949.HKD","LU1974910355.USD","LU1037948541.HKD","LU1116320737.USD","LU1116320901.HKD","LU1989771016.USD","IE00BJT1NW94.SGD","LU2023250504.SGD","LU1061106388.HKD","SGXZ57979304.SGD","LU1941712264.USD","LU1066053197.SGD","LU1917777945.USD","SG9999001440.SGD","BK4550","LU0203345920.USD","MRK","LU0208291251.USD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU1093756168.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.merck.com","stockEarnings":[{"period":"1week","weight":-0.0714},{"period":"1month","weight":-0.0254},{"period":"3month","weight":-0.1014},{"period":"6month","weight":-0.2312},{"period":"1year","weight":-0.3932},{"period":"ytd","weight":-0.2047}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.1126},{"period":"3month","weight":-0.0745},{"period":"6month","weight":-0.0619},{"period":"1year","weight":0.0851},{"period":"ytd","weight":-0.0425}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"默克制药公司于1970年在新泽西州注册成立。该公司是一家全球医疗保健公司，通过其处方药提供创新的健康解决方案，包括生物疗法、疫苗和动物保健产品。该公司的营运主要以产品为基础进行管理，包括两个经营分部：制药及动物保健国际。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.009524},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.001865},{"month":3,"riseRate":0.622222,"avgChangeRate":-0.002869},{"month":4,"riseRate":0.608696,"avgChangeRate":0.017086},{"month":5,"riseRate":0.630435,"avgChangeRate":0.01676},{"month":6,"riseRate":0.511111,"avgChangeRate":0.01265},{"month":7,"riseRate":0.488889,"avgChangeRate":0.003443},{"month":8,"riseRate":0.488889,"avgChangeRate":0.001677},{"month":9,"riseRate":0.533333,"avgChangeRate":-0.006327},{"month":10,"riseRate":0.533333,"avgChangeRate":0.018591},{"month":11,"riseRate":0.711111,"avgChangeRate":0.028573},{"month":12,"riseRate":0.6,"avgChangeRate":0.013993}],"exchange":"NYSE","name":"默沙东","nameEN":"Merck"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"默沙东,MRK,默沙东股票,默沙东股票老虎,默沙东股票老虎国际,默沙东行情,默沙东股票行情,默沙东股价,默沙东股市,默沙东股票价格,默沙东股票交易,默沙东股票购买,默沙东股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"默沙东(MRK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供默沙东(MRK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}